Mannheimia haemolytica (Newsom and Cross) Angen et al. (ATCC® BAA-409)

Strain Designations: SH1217  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations SH1217
isolation date: June 5, 1995
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype A1
Product Format freeze-dried
Preceptrol® no
Type Strain no
Antigenic Properties Serotype A1
Derivative of sequenced strain SH789
Medium ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor SK Highlander, ND Fedorova
Special Collection NSF - Bacteriology
isolation date: June 5, 1995
Year of Origin 1995

Fedorova ND, Highlander SK. Plasmids for heterologous expression in Pasteurella haemolytica. Gene 186: 207-211, 1997. PubMed: 9074498

Fedorova ND, Highlander SK. Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.. Infect. Immun. 65: 2593-2598, 1997. PubMed: 9199425

acridine orange curing of strain SH789

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
  • USDA APHIS VS 16-6 or 16-6A permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment. The Application Form VS 16-3 (Import controlled material import or transport organisms or vectors) must be submitted to USDA APHIS Veterinary Services to obtain the VS 16-6 or 16-6A permit.
Basic Documentation